Correlations between biomarkers for invasion/metastasis and patient clinical outcomes in rectal cancer (#60)

5:20 PM

Seong Beom Ahn

Prognostic factor for the patients with bone-only metastasis in breast cancer (#61)

5:20 PM

Sung Gwe Ahn

Rational combination therapy against triple-negative breast cancer (#62)

5:20 PM

Fares Al-Ejeh

Antibodies binding the ADAM10 substrate recognition pocket inhibit Eph function (#63)

5:20 PM

Lakmali Atapattu

Can Dicer explain decreased microRNA expression in lymph node metastases of triple negative breast cancer? (#64)

5:20 PM

Kelly A Avery-Kiejda

Association of Kallikrein gene variants with metastatic prostate cancer   (#65)

5:20 PM

Jyotsna Batra

Chromosomal Instability in BRAF Mutant, Microsatellite Stable Colorectal Cancers (#66)

5:20 PM

Catherine E Bond

Nanoparticles, cobalt complexes and tumour activatable pro-drug peptides: Hypoxia targeting strategies to inhibit tumour growth and metastasis (#67)

5:20 PM

Nicole S Bryce

Association of β-catenin with HPV Surrogate Marker p16 and Lymph Node Metastasis in Oropharyngeal Carcinoma (#68)

5:20 PM

Zhuo Georgia Chen

Inhibition of EGFR/Her-2 affects growth of ascitic ovarian cancer in vitro study (#69)

5:20 PM

Kenny Chitcholtan

Investigating the anti-proliferative activity of ginger-derived substances (#70)

5:20 PM

Marcia R Cominetti

Understanding metastatic breast cancer through an autopsy series (#71)

5:20 PM

Margaret C Cummings

SRF methylation in myofibroblasts predicts less metastasis of non-cardiac gastric carcinomas in China, Japan, and Korea (#72)

5:20 PM

Dajun Deng

The highly selective focal adhesion kinase inhibitor CTx-0294945 reduces tumour cell growth in an experimental metastasis model. (#73)

5:20 PM

J Doherty

Breast Cancer Network Australia - Working with you for results (#74)

5:20 PM

Nicca Grant

Evaluation of Surgical treatment of metastatic spinal tumors (#75)

5:20 PM

Wei Guo

YKL40 as a therapeutic target for the treatment of castration resistant prostate cancer (#76)

5:20 PM

Varinder Jeet

Fibroblast Growth Factor Receptor-2 Mutations in Endometrial Cancer (#77)

5:20 PM

Yvette Jeske

Engineering receptor based antagonists of the Gas6/Axl for therapeutic applications (#79)

5:20 PM

Yu Miao

Antitumor Effects of Anti-podoplanin Antibody NZ-1 against Malignant Mesothelioma (#80)

5:20 PM

Yasuhiko Nishioka

The Role of IQGAP1 in Ovarian Cancer Progression (#81)

5:20 PM

Sheri Nixdorf

Zoledronic acid facilitates large scale ex-vivo expansion of human γδ T cells for use in immunotherapy targeting bone metastases (#82)

5:20 PM

Vasilios Panagopoulos

Uncovering molecular mechanisms involved in metastasis to the brain (#83)

5:20 PM

Jodi M Saunus

Sub1 is a marker of aggressive breast cancer (#84)

5:20 PM

Wei Shi

Prediction of Postoperative Venous Thromboembolism in Patients with Malignancy of the Lower Extremity (#85)

5:20 PM

Seung Han Shin

Evidence for activation of signaling pathways that define the aggressive biology of TNBrCA in atypical breast lesions from high-risk African American women (#86)

5:20 PM

Adria Suarez

The Chemokine Receptor CXCR4 in Small Cell Lung Cancer (SCLC) and its role in metastasis (#87)

5:20 PM

Sanaz Taromi

B7-H3 - a new metastasis-promoting protein (#88)

5:20 PM

Christina Tekle

Esophageal squamous carcinoma and normal squamous epithelia express differentially glycosylated mucin 21 (#89)

5:20 PM

Yuan Tian

Paraneoplastic polyarteritis nodosa masquerading as widespread metastatic disease: A case report (#90)

5:20 PM

David Veitch

Differential expression of Kindlin-1 and Kindlin-2 during lung cancer progression (#91)

5:20 PM

Hongquan Zhang